Difficulty: Medium
Average Score: 89%
Practice
A 55-year-old patient that is receiving aerosol therapy with 0.9% saline is unable to produce an acceptable volume of sputum for a sample. Which of the following would you recommend at this time?
Correct answer
C
Rationale
The correct answer is C) Change to hypertonic saline.
Rationale:
Hypertonic saline is a mucolytic agent that can help in loosening thick secretions and promoting sputum production. In this case, the patient is unable to produce an acceptable volume of sputum with 0.9% saline, indicating the need for a more effective agent like hypertonic saline to aid in sputum clearance.
A) Initiate chest physiotherapy: While chest physiotherapy can be beneficial in mobilizing secretions, changing to a more effective mucolytic agent like hypertonic saline would be more appropriate in this scenario.
B) Administer the aerosol continuously: Continuous administration of the aerosol may not address the underlying issue of inadequate sputum production. Changing the type of solution to hypertonic saline would be a more targeted approach.
D) Perform nasotracheal suctioning: Suctioning should be reserved for patients with excessive secretions that are causing airway obstruction. In this case, changing to hypertonic saline would be a more appropriate initial intervention before considering suctioning.
Educational context:
Understanding the different mucolytic agents and their indications is crucial in respiratory therapy. Hypertonic saline is commonly used to help patients with conditions like cystic fibrosis or chronic obstructive pulmonary disease to clear thick secretions effectively. Knowing when to switch to a more potent mucolytic agent based on the patient's response to therapy is essential in optimizing patient care and outcomes.
Rationale:
Hypertonic saline is a mucolytic agent that can help in loosening thick secretions and promoting sputum production. In this case, the patient is unable to produce an acceptable volume of sputum with 0.9% saline, indicating the need for a more effective agent like hypertonic saline to aid in sputum clearance.
A) Initiate chest physiotherapy: While chest physiotherapy can be beneficial in mobilizing secretions, changing to a more effective mucolytic agent like hypertonic saline would be more appropriate in this scenario.
B) Administer the aerosol continuously: Continuous administration of the aerosol may not address the underlying issue of inadequate sputum production. Changing the type of solution to hypertonic saline would be a more targeted approach.
D) Perform nasotracheal suctioning: Suctioning should be reserved for patients with excessive secretions that are causing airway obstruction. In this case, changing to hypertonic saline would be a more appropriate initial intervention before considering suctioning.
Educational context:
Understanding the different mucolytic agents and their indications is crucial in respiratory therapy. Hypertonic saline is commonly used to help patients with conditions like cystic fibrosis or chronic obstructive pulmonary disease to clear thick secretions effectively. Knowing when to switch to a more potent mucolytic agent based on the patient's response to therapy is essential in optimizing patient care and outcomes.